Global, regional, and national burden of breast cancer among females, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023
global breast cancer burden 1990-2023, GBD 2023 breast cancer incidence mortality, breast cancer epidemiology developing countries, female breast cancer forecasts 2050, regional breast cancer mortality trends, breast cancer DALYs systematic analysis, Global Burden of Disease breast cancer, breast cancer incidence age-standardized rates, women's cancer global health burden, breast cancer prevention population-level data
PMID 41785894 41785894 DOI 10.1016/S1470-2045(25)00730-2 10.1016/S1470-2045(25)00730-2
Cite this article
GBD 2023 Breast Cancer Collaborators (2026). Global, regional, and national burden of breast cancer among females, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. *The Lancet Oncology*, *27*(3), 302-326. https://doi.org/10.1016/S1470-2045(25)00730-2
GBD 2023 Breast Cancer Collaborators. Global, regional, and national burden of breast cancer among females, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet Oncology. 2026;27(3):302-326. doi:10.1016/S1470-2045(25)00730-2
GBD 2023 Breast Cancer Collaborators. "Global, regional, and national burden of breast cancer among females, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023." *The Lancet Oncology*, vol. 27, no. 3, 2026, pp. 302-326.
No Authors Listed, 2012
Open Access
The Lancet. Oncology
Background: Menarche and menopause mark the onset and cessation, respectively, of ovarian activity associated with reproduction, and affect breast cancer risk. Our aim was to assess the strengths of t...